Botswana Health News API

{
    "totalArticles": 1922,
    "articles": [
        {
            "id": "404d5ad4b2f148ddd5fe3f547105108c",
            "title": "More than one-third of parents assume children need antibiotics for ear infections",
            "description": "The Pharmaceutical Journal from the Royal Pharmaceutical Society",
            "content": "More than one in three parents believe children always need antibiotics for ear infections, according to a UK Health Security Agency (UKHSA) survey.\nData suggest that between 50% and 85% of children will develop at least one acute otitis media (AOM) ... [2461 chars]",
            "url": "https://pharmaceutical-journal.com/article/news/more-than-one-third-of-parents-assume-children-need-antibiotics-for-ear-infections",
            "image": "https://pharmaceutical-journal.com/wp-content/uploads/2026/03/More-than-one-third-of-parents-assume-children-need-antibiotics-for-ear-infections.jpg",
            "publishedAt": "2026-03-16T21:11:15Z",
            "lang": "en",
            "source": {
                "id": "59f6e4b398e15af75182728038b9a0fc",
                "name": "The Pharmaceutical Journal",
                "url": "https://pharmaceutical-journal.com"
            }
        },
        {
            "id": "fd8694fe6b32ab3189578bf62c48a73c",
            "title": "Apixaban Bests Rivaroxaban for Bleeding in VTE: COBBRA",
            "description": "In an editorial, one expert said the choice of DOAC in VTE is “no longer a toss-up,” with apixaban the clear winner.",
            "content": "Patients treated with apixaban (Eliquis; Bristol Myers Squibb) for 3 months after acute venous thromboembolism (VTE) report more than half the rate of clinically relevant bleeding compared with those taking rivaroxaban (Xarelto; Bayer/Janssen), accor... [5451 chars]",
            "url": "https://www.tctmd.com/news/apixaban-bests-rivaroxaban-bleeding-vte-cobbra",
            "image": "https://d14d5nk8lue86f.cloudfront.net/s3fs-public/2026-03/Apixaban%20Bests%20Rivaroxaban%20for%20Bleeding%20in%20VTE%20COBBRA.jpg",
            "publishedAt": "2026-03-16T20:58:25Z",
            "lang": "en",
            "source": {
                "id": "6f1cf3918c9974e771cdda266d6941f0",
                "name": "TCTMD.com",
                "url": "https://www.tctmd.com"
            }
        },
        {
            "id": "6e7bfd136e159461f62db6582f450d2d",
            "title": "The Role of ctDNA in HR+ Breast Cancer: Evidence, Challenges & Future Directions",
            "description": "In the final segment, the conversation shifts to ctDNA and MRD testing: benefits, limits, and real‑world use.",
            "content": "Transcript\nDr. Iyengar: Great discussion, but we’ll move on again. And we’ve talked a little bit about circulating tumor DNA in the context of risk stratification. Let’s focus on that a little bit more and start in the early stage setting. Kit, are y... [8254 chars]",
            "url": "https://www.docwirenews.com/post/the-role-of-ctdna-in-hr-breast-cancer-evidence-challenges-future-directions",
            "image": "https://mumcdnstorage.blob.core.windows.net/dwnews/2026/03/BRCST_YT_ctDNA-in-HR-Breast-Cancer_1280x720.jpg",
            "publishedAt": "2026-03-16T20:58:24Z",
            "lang": "en",
            "source": {
                "id": "885ae2dda50884da7e0cf7fb8d4aa961",
                "name": "Docwire News",
                "url": "https://www.docwirenews.com"
            }
        }
    ]
}